Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000120

Chief Medical Officer sold 30,000 shares at $30.48 ($914,400)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Gheuens Sarah · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-08-04 Sale : show line 1 in the form 10b5-1 −30,000 $30.48 $914,400 54,645 D
Open-market sales · 30,000 sh · avg $30.48 · $914,400
Loading xslF345X06/wk-form4_1786047196.xml…